Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/28278
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2022-08-19T07:56:31Z | - |
dc.date.available | 2022-08-19T07:56:31Z | - |
dc.date.issued | 2007-04 | - |
dc.identifier.citation | Taş, S. vd. (2007). "Vanadyl sulfate, taurine, and combined vanadyl sulfate and taurine treatments in diabetic rats: Effects on the oxidative and antioxidative systems". Archives of Medical Research , 38(3), 276-283. | en_US |
dc.identifier.issn | 0188-4409 | - |
dc.identifier.issn | 1873-5487 | - |
dc.identifier.uri | https://doi.org/10.1016/j.arcmed.2006.09.018 | - |
dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S0188440906003754 | - |
dc.identifier.uri | http://hdl.handle.net/11452/28278 | - |
dc.description.abstract | Background. Vanadyl sulfate (VS) and taurine are two promising agents in the treatment of diabetes related to their anti hyperglycemic, antihyperlipidemic, and hyperinsulinemic effects. Data about the effects of VS on the oxidant-antioxidant system is limited and controversial. However, taurine is a well-documented antioxidant agent and our aim was to investigate the effects of VS, taurine and VS and taurine combination on the oxidative-antioxidative systems in streptozotocin-nicotinamide (STZ-NA) diabetic rats. Methods. Nicotinamide (230 mg/kg, i.p.) and streptozotocin (65 mg/kg, i.p.) were administered. VS (0.75 mg/mL) and taurine (1%) were added to drinking water for 5 weeks. Rats were divided as control (C), diabetes (D), diabetes + VS (D + VS), diabetes + taurine (D + T), diabetes + VS and taurine (D + VST). Plasma and tissue malondialdehyde (MDA) levels were measured by high-performance liquid chromatography and spectrophotometry, respectively. Paraoxonase and arylesterase activities were measured by spectrophotometric methods and superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) activities were determined using commercial kits. Results. VS, taurine and VS and taurine combination treatments reduced the enhanced blood glucose, serum total cholesterol and triglyceride, tissue NIDA and plasma MDA (except in the D + VS group) levels and increased the reduced serum insulin level, serum paraoxonase and arylesterase activities, GSH-Px activity and SOD activity (except in the D + VS group). Conclusions. The findings of the present study suggest that VS and taurine exert beneficial effects on the blood glucose and lipid levels in STZ-NA diabetic rats. However, VS might exert prooxidative or antioxidative effects in various components of the body and taurine and VS combination might be an alternative for sole VS administration. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Science | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Nicotinamide | en_US |
dc.subject | Oxidative stress | en_US |
dc.subject | Paraoxonase | en_US |
dc.subject | Streptozotocin | en_US |
dc.subject | Taurine | en_US |
dc.subject | Vanadyl sulfate | en_US |
dc.subject | Erythrocyte lipid-peroxidation | en_US |
dc.subject | Human-serum paraoxonase | en_US |
dc.subject | Vascular complications | en_US |
dc.subject | Insulin sensitivity | en_US |
dc.subject | Fatty rat | en_US |
dc.subject | In-vitro | en_US |
dc.subject | Mellitus | en_US |
dc.subject | Streptozotocin | en_US |
dc.subject | Stress | en_US |
dc.subject | Metabolism | en_US |
dc.subject.mesh | Diabetes mellitus, experimental | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Antioxidants | en_US |
dc.subject.mesh | Blood glucose | en_US |
dc.subject.mesh | Hypoglycemic agents | en_US |
dc.subject.mesh | Liver | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Malondialdehyde | en_US |
dc.subject.mesh | Myocardium | en_US |
dc.subject.mesh | Oxidation-reduction | en_US |
dc.subject.mesh | Muscle, skeletal | en_US |
dc.subject.mesh | Oxidants | en_US |
dc.subject.mesh | Oxidative stress | en_US |
dc.subject.mesh | Rats | en_US |
dc.subject.mesh | Rats, wistar | en_US |
dc.subject.mesh | Taurine | en_US |
dc.subject.mesh | Vanadium compounds | en_US |
dc.title | Vanadyl sulfate, taurine, and combined vanadyl sulfate and taurine treatments in diabetic rats: Effects on the oxidative and antioxidative systems | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000245449400002 | tr_TR |
dc.identifier.scopus | 2-s2.0-33847651747 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Fen-Edebiyat Fakültesi/Biyoloji Bölümü. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Biyokimya Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0002-2593-7196 | tr_TR |
dc.contributor.orcid | 0000-0002-0909-618X | tr_TR |
dc.identifier.startpage | 276 | tr_TR |
dc.identifier.endpage | 283 | tr_TR |
dc.identifier.volume | 38 | tr_TR |
dc.identifier.issue | 3 | tr_TR |
dc.relation.journal | Archives of Medicine Research | en_US |
dc.contributor.buuauthor | Taş, Sibel | - |
dc.contributor.buuauthor | Sarandol, Emre | - |
dc.contributor.buuauthor | Ayvalık, Sedef Ziyanok | - |
dc.contributor.buuauthor | Serdar, Zehra | - |
dc.contributor.buuauthor | Dirican, Melahat | - |
dc.contributor.researcherid | AAH-6200-2021 | tr_TR |
dc.contributor.researcherid | ABE-1716-2020 | tr_TR |
dc.contributor.researcherid | ABE-6873-2020 | tr_TR |
dc.contributor.researcherid | AAG-6985-2021 | tr_TR |
dc.identifier.pubmed | 17350476 | tr_TR |
dc.subject.wos | Medicine, research & experimental | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q3 | en_US |
dc.contributor.scopusid | 7004343411 | tr_TR |
dc.contributor.scopusid | 55943324800 | tr_TR |
dc.contributor.scopusid | 16027717500 | tr_TR |
dc.contributor.scopusid | 57222002284 | tr_TR |
dc.contributor.scopusid | 6601919847 | tr_TR |
dc.subject.scopus | Bis(Acetylacetonato)Oxovanadium(IV); Vanadium Compounds; Oxovanadium IV | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Aerobic metabolism | en_US |
dc.subject.emtree | Animal cell | en_US |
dc.subject.emtree | Animal experiment | en_US |
dc.subject.emtree | Animal model | en_US |
dc.subject.emtree | Animal tissue | en_US |
dc.subject.emtree | Antioxidant activity | en_US |
dc.subject.emtree | Cholesterol blood level | en_US |
dc.subject.emtree | High performance liquid chromatography | en_US |
dc.subject.emtree | Superoxide dismutase | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Diabetes mellitus | en_US |
dc.subject.emtree | Enzyme activity | en_US |
dc.subject.emtree | Glucose blood level | en_US |
dc.subject.emtree | Nonhuman | en_US |
dc.subject.emtree | Vanadyl sulfate | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Rat | en_US |
dc.subject.emtree | Spectrophotometry | en_US |
dc.subject.emtree | Triacylglycerol blood level | en_US |
dc.subject.emtree | Aryldialkylphosphatase | en_US |
dc.subject.emtree | Nicotinamide | en_US |
dc.subject.emtree | Arylesterase | en_US |
dc.subject.emtree | Cholesterol | en_US |
dc.subject.emtree | Glucose | en_US |
dc.subject.emtree | Glutathione peroxidase | en_US |
dc.subject.emtree | Malonaldehyde | en_US |
dc.subject.emtree | Streptozocin | en_US |
dc.subject.emtree | Taurine | en_US |
dc.subject.emtree | Triacylglycerol | en_US |
Appears in Collections: | PubMed Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.